Literature DB >> 16331961

The seventh transmembrane domains of the delta and kappa opioid receptors have different accessibility patterns and interhelical interactions.

Wei Xu1, Mercedes Campillo, Leonardo Pardo, J Kim de Riel, Lee-Yuan Liu-Chen.   

Abstract

We applied the substituted cysteine accessibility method (SCAM) to map the residues of the transmembrane helices (TMs) 7 of delta and kappa opioid receptors (deltaOR and kappaOR) that are on the water-accessible surface of the binding-site crevices. A total of 25 consecutive residues (except C7.38) in the TMs 7 were mutated to Cys, one at a time, and each mutant was expressed in HEK 293 cells. Most mutants displayed similar binding affinity for [(3)H]diprenorphine, an antagonist, as the wild types. Pretreatment with (2-aminoethyl)methanethiosulfonate (MTSEA) inhibited [(3)H]diprenorphine binding to eight deltaOR and eight kappaOR mutants. All mutants except deltaOR L7.52(317)C were protected by naloxone from the MTSEA effect, indicating that the side chains of V7.31(296), A7.34(299), I7.39(304), L7.41(306), G7.42(307), P7.50(315), and Y7.53(318) of deltaOR and S7.34(311), F7.37(314), I7.39(316), A7.40(317), L7.41(318), G7.42(319), Y7.43(320), and N7.49(326) of kappaOR are on the water-accessible surface of the binding pockets. Combining the SCAM data with rhodopsin-based molecular models of the receptors led to the following conclusions. (i) The residues of the extracellular portion of TM7 predicted to face TM1 are sensitive to MTSEA in kappaOR but are not in deltaOR. Thus, TM1 may be closer to TM7 in deltaOR than in kappaOR. (ii) MTSEA-sensitive mutants start at position 7.31(296) in deltaOR and at 7.34(311) in kappaOR, suggesting that TM7 in deltaOR may have an additional helical turn (from 7.30 to 7.33). (iii) There is a conserved hydrogen-bond network linking D2.50 of the NLxxxD motif in TM2 with W6.48 of the CWxP motif in TM6. (iv) The NPxxY motif in TM7 interacts with TM2, TM6, and helix 8 to maintain receptors in inactive states. To the best of our knowledge, this represents the first such comparison of the structures of two highly homologous GPCRs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16331961      PMCID: PMC2688720          DOI: 10.1021/bi050938a

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  62 in total

1.  Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.

Authors:  J A Javitch; J A Ballesteros; J Chen; V Chiappa; M M Simpson
Journal:  Biochemistry       Date:  1999-06-22       Impact factor: 3.162

2.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation.

Authors:  Olaf Fritze; Sławomir Filipek; Vladimir Kuksa; Krzysztof Palczewski; Klaus Peter Hofmann; Oliver P Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

3.  Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.

Authors:  Cédric Govaerts; Antoine Bondue; Jean-Yves Springael; Mireia Olivella; Xavier Deupi; Emmanuel Le Poul; Shoshana J Wodak; Marc Parmentier; Leonardo Pardo; Cédric Blanpain
Journal:  J Biol Chem       Date:  2002-10-30       Impact factor: 5.157

4.  On the use of thiol-modifying agents to determine channel topology.

Authors:  M Holmgren; Y Liu; Y Xu; G Yellen
Journal:  Neuropharmacology       Date:  1996       Impact factor: 5.250

5.  Substituted-cysteine accessibility method.

Authors:  A Karlin; M H Akabas
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

6.  Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands.

Authors:  M Valiquette; H K Vu; S Y Yue; C Wahlestedt; P Walker
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

7.  Location of regions of the opioid receptor involved in selective agonist binding.

Authors:  K Fukuda; S Kato; K Mori
Journal:  J Biol Chem       Date:  1995-03-24       Impact factor: 5.157

8.  A practical computer-based approach to the analysis of radioligand binding experiments.

Authors:  G A McPherson
Journal:  Comput Programs Biomed       Date:  1983 Aug-Oct

9.  The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.

Authors:  Mannix Auger-Messier; Martin Clement; Pascal M Lanctot; Patrice C Leclerc; Richard Leduc; Emanuel Escher; Gaetan Guillemette
Journal:  Endocrinology       Date:  2003-08-13       Impact factor: 4.736

10.  The third extracellular loop of the mu opioid receptor is important for agonist selectivity.

Authors:  J C Xue; C Chen; J Zhu; S P Kunapuli; J K de Riel; L Yu; L Y Liu-Chen
Journal:  J Biol Chem       Date:  1995-06-02       Impact factor: 5.157

View more
  5 in total

1.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Authors:  Gene L Garcia; Maoqing Dong; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

2.  Structure-based design, synthesis, and biochemical and pharmacological characterization of novel salvinorin A analogues as active state probes of the kappa-opioid receptor.

Authors:  Feng Yan; Ruslan V Bikbulatov; Viorel Mocanu; Nedyalka Dicheva; Carol E Parker; William C Wetsel; Philip D Mosier; Richard B Westkaemper; John A Allen; Jordan K Zjawiony; Bryan L Roth
Journal:  Biochemistry       Date:  2009-07-28       Impact factor: 3.162

3.  Dynorphin peptides differentially regulate the human kappa opioid receptor.

Authors:  Yong Chen; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2007-01-20       Impact factor: 5.037

Review 4.  Visualizing water molecules in transmembrane proteins using radiolytic labeling methods.

Authors:  Tivadar Orban; Sayan Gupta; Krzysztof Palczewski; Mark R Chance
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

5.  Structure and activation of the TSH receptor transmembrane domain.

Authors:  Ricardo Núñez Miguel; Jane Sanders; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Auto Immun Highlights       Date:  2016-12-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.